Literature DB >> 30616104

An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish.

Nusrat Khan1, Nilesh Kumar Mahajan1, Pradip Sinha1, Giridhara R Jayandharan2.   

Abstract

Zebrafish is emerging as a promising model for the study of human cancers. Several xenograft models of zebrafish have been developed, particularly in larval stages (<48 h post fertilization) when the immune system of fish is not developed. However, xenografting in adult zebrafish requires laborious and transient methods of immune suppression (γ- irradiation or dexamethasone) that limits engraftment and survival of the tumor or fail to recapitulate specific characteristics of malignancies. Thus, the availability of a simple protocol to successfully engraft adult zebrafish, remains a challenge. The current study addresses this limitation and describes a robust method of xenografting in adult zebrafish. We describe a protocol that involves pre-conditioning of Casper, a pigmentation mutant of zebrafish with busulfan that led to a higher rate of engraftment of hepatocellular carcinoma and acute myeloid leukemia cells. To further ascertain the homing characteristics of the injected cancer cells, we transplanted adult zebrafish by two routes of administration and then studied their compartmentalization. This model presents a valuable alternative to rodents to study the biology of these cancers and also a cost-effective platform for evaluation of potential anti-cancer agents.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Alternative animal model; Busulfan; Hepatocellular carcinoma; Immune suppression; Xenotransplantation; Zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30616104     DOI: 10.1016/j.bcmd.2018.12.007

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

Review 1.  What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine.

Authors:  María Cascallar; Sandra Alijas; Alba Pensado-López; Abi Judit Vázquez-Ríos; Laura Sánchez; Roberto Piñeiro; María de la Fuente
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 2.  Vector engineering, strategies and targets in cancer gene therapy.

Authors:  Vijayata Singh; Nusrat Khan; Giridhara R Jayandharan
Journal:  Cancer Gene Ther       Date:  2021-04-15       Impact factor: 5.987

Review 3.  Zebrafish models of acute leukemias: Current models and future directions.

Authors:  Brandon Molina; Jasmine Chavez; Stephanie Grainger
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-12-19       Impact factor: 5.814

Review 4.  Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.

Authors:  Martina Hason; Petr Bartůněk
Journal:  Genes (Basel)       Date:  2019-11-15       Impact factor: 4.096

Review 5.  Zebrafish Models to Study the Crosstalk between Inflammation and NADPH Oxidase-Derived Oxidative Stress in Melanoma.

Authors:  Irene Pardo-Sánchez; Diana García-Moreno; Victoriano Mulero
Journal:  Antioxidants (Basel)       Date:  2022-06-28

6.  Development of a Multicellular 3D Tumor Model to Study Cellular Heterogeneity and Plasticity in NSCLC Tumor Microenvironment.

Authors:  Leena Arora; Moyna Kalia; Suman Dasgupta; Navneet Singh; Anita K Verma; Durba Pal
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

Review 7.  Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment.

Authors:  Pablo Cabezas-Sáinz; Alba Pensado-López; Bruno Sáinz; Laura Sánchez
Journal:  Cells       Date:  2020-08-27       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.